TRR 274 PhD students Caitlin Gillespie (LMU) and Annika Meilin Schmidke (UMG) participated in an advanced microscopy retreat organized by TRR member Thomas Misgeld (Project B03 and C02) in Berchtesgaden from September 28 to October 2, 2026. The intensive hands-on course brought together researchers for practical training in building both widefield and light-sheet microscopes, as…
TRR 274 Young Invistigator Retreat 2026 in Lohr am Main From 22–24 July 2026, the TRR 274 Young Investigators gathered for their annual retreat in the beautiful surroundings of Lohr am Main. Over two days, early-career researchers presented their latest work and reflected on the progress achieved over the past year through a series of…
From July 06-10, 2026, TRR 274 was represented at the booth of the Network of German Neuroscience Centers during the Conference of the Federation of European Neuroscience Societies (FENS) in Barcelona, Spain. The Neurocenters in Germany network brings together major neuroscience research centers and funding organizations across the country. Its mission is to promote Germany…
Congratulations to our speaker Martin Kerschensteiner on receiving an European Research Council (ERC) Advanced Grant! With his project TACO (Targeting myeloid cell states, actions and interactions in neuroinflammation), Prof. Kerschensteiner aims to unlock multi-omics datasets for the development of more precise, stage- and lesion-specific therapeutic strategies, with potential relevance beyond MS to other neuroinflammatory diseases….
Congratulations to our member Thomas Misgeld, neuroscientist at DZNE’s Munich site, and Director of the Institute of Neuronal Cell Biology at the Technical University of Munich (TUM), that received his membership certificate from the German National Academy of Sciences Leopoldina. This distinction recognizes his outstanding contributions to the neurosciences. Read more about on the DZNE…
TRR 274 was delighted to support the fourth Munich Brain Day, an event that continues to foster exchange and collaboration within Munich’s vibrant neuroscience community. Among the highlights of this year’s meeting was the presentation by Anna-Sophia Wahl (Project C06), a valued member of the TRR 274 network. The poster session provided an excellent platform…
Careers Day at the IMSF
Background Regulatory T (Treg) cells expressing the transcription factor Foxp3 are essential for maintaining immune tolerance and preventing autoimmunity. While their systemic immunosuppressive role is well established, less is understood about how Treg cells function within specific tissues after inflammation resolves. In autoimmune diseases affecting the central nervous system (CNS), such as multiple sclerosis, inflammation…
We are pleased to announce the handover of the coordination of TRR 274. As of January 30 2026, Camilla Giudici has taken over the coordination role from Adinda Wens. We sincerely thank Adinda for her dedication, commitment, and many years of coordination, which have contributed to the success and cohesion of the consortium. We warmly…
Congratulations to our member Arthur Liesz on receiving an European Research Council (ERC) Consolidator Grant! With his ERC project TRAINED, Arthur will study how the immune system can develop a long-lasting “memory” after injuries like stroke. This trained immunity can become dysregulated and drive chronic inflammation throughout the body, long after the initial injury. Read…
TRR 274 Annual Retreat in San Servolo, Venice On 29–30 October, the TRR 274 community gathered for our annual retreat on the island of San Servolo in Venice, Italy. Over two days, project leaders and early career researchers shared progress from the past year through a series of engaging presentations. A dedicated PI meet and…
Background In Multiple Sclerosis (MS), focal lesions and white matter pathology have been long studied. Grey matter changes however, particularly in the cortex, are increasingly recognised as strong predictors of progression, disability and cognitive decline. In-vivo detection of cortical synapse loss, an early indicator of grey matter pathology, has remained challenging. Aims The study set…
